Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1992;23:1499-1503

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayhan, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayhan, W. G.

Stroke, Vol 23, 1499-1503, Copyright © 1992 by American Heart Association


ARTICLES

Effect of diabetes mellitus on responses of the basilar artery in rats to products released by platelets

WG Mayhan
Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha 68198.

BACKGROUND AND PURPOSE: Aggregation and adherence of platelets to vascular endothelium are increased during diabetes mellitus, and thus responses of cerebral arteries to products released by platelets may have important implications for the pathogenesis of stroke during diabetes. The goal of this study was to determine whether responses of the basilar artery to products released by platelets are altered during diabetes. METHODS: A craniotomy was performed over the ventral medulla to expose the basilar artery. Diameter of the basilar artery was measured using intravital microscopy in nondiabetic and diabetic (50-60 mg/kg i.p. streptozotocin) rats in response to adenosine 5'- diphosphate, serotonin, and the thromboxane analogue U-46619. RESULTS: Topical application of 10 and 100 microM adenosine 5'-diphosphate produced only minimal changes in diameter of the basilar artery that were similar in nondiabetic and diabetic rats (p greater than 0.05). At 0.01, 0.1, and 1.0 microM serotonin produced dose-related constriction of the basilar artery that was similar in nondiabetic and diabetic rats (p greater than 0.05). At 0.1 and 1.0 microM U-46619 also produced similar dose-related constriction of the basilar artery in nondiabetic and diabetic rats (p greater than 0.05). CONCLUSIONS: These findings suggest that responses of the basilar artery to products released by platelets are not altered by diabetes mellitus. Thus, it does not appear that alterations in reactivity of the basilar artery to products released by platelets contribute to the pathogenesis of stroke during diabetes.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Didion, C. M. Lynch, and F. M. Faraci
Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1579 - H1583.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. Phillips, F. A. Sylvester, and J. C. Frisbee
Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R522 - R530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Erdos, J. A. Snipes, B. Kis, A. W. Miller, and D. W. Busija
Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1456 - R1461.
[Abstract] [Full Text] [PDF]